Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency. - Wikidata - wikimedia - TriplyDB

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

http://www.wikidata.org/entity/Q35861936

about

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives Oncolysis by paramyxoviruses: preclinical and clinical studies.Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs.Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines.Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620).Potential and clinical translation of oncolytic measles viruses.Avian Paramyxovirus Type-3 as a Vaccine Vector: Identification of a Genome Location for High Level Expression of a Foreign Gene.Complete Genome Sequence of the Oncolytic Sendai virus Strain Moscow.Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).Fusogenic Viruses in Oncolytic Immunotherapy

P2860

Q26775030-50520A6E-9093-4F23-BA60-DB82BE571B3A Q33679505-C6029CEB-BEFF-45CD-B31E-638846FD3009 Q35861933-627E7842-80F3-41E7-964E-66110D54F50A Q36169226-C88A231E-5816-4EC1-9F8A-626405048B03 Q38695916-512CC592-4056-4F5E-8A6A-3E47F7CFB2DD Q38701351-9AE776C1-E7FF-4608-B6CC-681F6AE38DF3 Q38764947-5353E501-5022-45BD-B331-16E7EEDEAAF4 Q40214432-D75E8203-3DB8-4F01-A310-360533FB9066 Q40625069-DB726C32-A814-4A2E-BE67-8DC6D08B274C Q50128059-3C40FA6A-E281-464E-BA82-B4275B7FCAAB Q55366271-645DE721-8813-4019-BBB2-BB430E791F2E Q56971929-872FA93A-33CB-4400-AABD-2C0C3FC16488

P2860

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

http://www.wikidata.org/entity/Q35861936

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@ast

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@en

type

label

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@ast

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@en

prefLabel

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@ast

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@en

P1433

Q35861936-54828711-6210-4B6C-9BEB-AC5A29407319

P1476

Q35861936-9841AE99-36F2-49C0-9597-E0029F0E118B

P2093

Q35861936-14E14221-C53A-4B77-AB74-312A9123D7A0

Q35861936-B1BB13B6-4A1C-40C1-A3A7-32E126979F41

Q35861936-E06A7A27-4D7A-4DBF-8621-1346DBD079DF

P2860

Q35861936-01A98249-14D4-49DF-9923-EBAE8B6FBD9D

Q35861936-0670CFFD-26D6-4F90-B1FA-727830161C67

Q35861936-06AFD962-1C66-45E3-B803-C9A6441ABA45

Q35861936-07732DC9-FACE-4253-8376-AE258A7AE0B7

Q35861936-098F12DE-D7B7-44D9-978B-4534D0D14E5B

Q35861936-09B0E65C-6EBD-49A1-835B-D428BB003003

Q35861936-0D726356-DE27-412F-9BB1-B31C6B48481B

Q35861936-0DA2FBEF-7206-4502-949A-650602E859AA

Q35861936-0DBEF546-CE18-4EE4-B4D0-8E73CAD48D6F

Q35861936-0F7B5B85-4C7F-4D0F-BBAE-0437D46E8325

P31

Q35861936-06C24C5D-322D-4746-B460-C7DFF4BC29B7

P356

Q35861936-065DDDAB-56B1-4C6A-AF09-1E228C198394

P478

Q35861936-06C6FB6F-9B93-45E4-9C93-7F0A5B2BB96D

P50

Q35861936-FF1D69B6-5061-451E-92B1-A90960F026F0

P577

Q35861936-FF80E3C4-89BD-4900-84B6-5207BEE6D9FE

P5875

Q35861936-C4B9EFC2-81A0-47EF-A21C-856F7EB7ADB8

P698

Q35861936-B4F668BE-0A15-4C00-BFDD-C6C395EC3210

P932

Q35861936-4EEDB122-08A7-4941-8A4D-19810235DB1D

P356

P1433

Molecular therapy oncolytics

P1476

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

@en

P2093

Olga V Matveeva

http://www.w3.org/2001/XMLSchema#string

Svetlana A Shabalina

http://www.w3.org/2001/XMLSchema#string

Zong S Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Oncolytic viruses as therapeutic cancer vaccines

Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes

New viruses for cancer therapy: meeting clinical needs

Genetically engineered Newcastle disease virus for malignant melanoma therapy

Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells

Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction

Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death

Functional and structural interactions between measles virus hemagglutinin and CD46

P31

scholarly article

P356

10.1038/MTO.2015.11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Peter M. Chumakov

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280554586

http://www.w3.org/2001/XMLSchema#string

P698

26640816

http://www.w3.org/2001/XMLSchema#string

P932

4667958

http://www.w3.org/2001/XMLSchema#string